BEONE MEDICINES (06160) releases its performance for the first three quarters, with a net profit attributable to the parent company of 1.139 billion yuan, turning a loss into a profit year-on-year.
Baiji Shenzhou (06160) released its performance for the first three quarters of 2025, with the group achieving operating income of RMB 275...
BEONE MEDICINES (06160) released its performance for the first three quarters of 2025, with the group achieving operating income of RMB 27.595 billion, a year-on-year increase of 44.2%; net profit attributable to shareholders of the listed company was RMB 1.139 billion, turning from a loss to a profit year-on-year; basic earnings per share were RMB 0.81.
Related Articles
iSoftStone Information Technology (301236.SZ) applies to issue shares to specific targets and receives approval from the Shenzhen Stock Exchange.
Subsidiary of Nanfang Pump Industry (300145.SZ) plans to sell some of its assets.
IBM's new quantum processor, Nighthawk, will be launched by the end of the year, moving towards the fault-tolerant era in 2029.
iSoftStone Information Technology (301236.SZ) applies to issue shares to specific targets and receives approval from the Shenzhen Stock Exchange.
Subsidiary of Nanfang Pump Industry (300145.SZ) plans to sell some of its assets.
IBM's new quantum processor, Nighthawk, will be launched by the end of the year, moving towards the fault-tolerant era in 2029.
RECOMMEND
Younger consumers are dining out less at Chipotle and Cava while still buying Coach handbags
10/11/2025
Target’s deteriorating in-store experience risks recovery — retailer bets on a refined fulfillment model to fix it
10/11/2025
China suspends approval ban on exports of certain metals used in chip and electronics manufacturing to the U.S.
10/11/2025
